Moreover, the miR-27a inhibitor and miR-155 inhibitor could also weaken the effects of Bmi-1 overexpression on migration, invasion and chemoresistance in gastric cancer cells (Fig. S4 and Fig. S3C). Here, BMI1 is linked to gastric cancer.